Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor
Farouc A. Jaffer,Dong-Eog Kim,Luisa Quinti,Ching-Hsuan Tung,Elena Aikawa,Ashvin N. Pande,Rainer H. Kohler,Guo-Ping Shi,Peter Libby,Ralph Weissleder +9 more
278
TL;DR: Use of this novel protease-activatable NIRF agent for optical imaging in vivo demonstrated preferential localization of enzymatically active CatK to macrophages, consistent with their known greater elastinolytic capabilities compared with smooth muscle cells.
read more
Abstract: Background— Cathepsin K (CatK), a potent elastinolytic and collagenolytic cysteine protease, likely participates in the evolution and destabilization of atherosclerotic plaques. To assess better the biology of CatK activity in vivo, we developed a novel near-infrared fluorescence (NIRF) probe for imaging of CatK and evaluated it in mouse and human atherosclerosis. Methods and Results— The NIRF imaging agent consists of the CatK peptide substrate GHPGGPQGKC-NH2 linked to an activatable fluorogenic polymer. In vitro, CatK produced a 2- to 14-fold activation of the agent over other cysteine and matrix metalloproteinases (P 8-fold activation over a control imaging agent (P 100% NIRF signal increases in apolipoprotein E−/− mice in vivo (n=13; P<0.05, CatK imaging agent versus control agent) and in human carotid endarterectomy specimens ex vivo (n=14; P<0.05). Fluorescence microscopy of plaque sections demonstrated that enzymatically active Ca...
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
New targets of molecular imaging in atherosclerosis: prehension of current status.
TL;DR: This review summarizes the current status of atherosclerosis imaging aimed at macrophage-related, direct Macrophage and non-macrophage as target molecules during different stages of atherogenesis and presents activated macrophages, biofilm and amyloid fibrils as possible new targets for the development of non-invasive imaging probes to assess atheros sclerosis.
3
Progress and Perspective of Atherosclerosis-Targeted Molecular Probes: From Precise Imaging to Auxiliary Diagnosis and Treatment
Cong Hu,Zhipengjun Zhang,Shanyi Sun,Hong-Wen Liu,Lin Yuan,Xiaobin Zhang +5 more
TL;DR: This review discusses the development of molecular probes for atherosclerosis imaging, diagnosis, and treatment, highlighting their potential for non-invasive detection and precise identification of disease sites, and emphasizing challenges and prospects in the field.
3
Dual-Mechanism Quenched Fluorogenic Probe Provides Selective and Rapid Detection of Cathepsin L Activity**
Kelton A. Schleyer,Kelton A. Schleyer,Ben Fetrow,Peter Zannes Fatland,Jun Liu,Jun Liu,Maya Chaaban,Biwu Ma,Lina Cui,Lina Cui +9 more
TL;DR: A fluorogenic probe is developed that displays good selectivity for CTL over CTB and CTV while exhibiting low background fluorescence attributed to dual quenching mechanisms, suggesting that it is amenable for rapid detection of CTL, even in the presence of competing cathepsins.
Sensors for Proteolytic Activity Visualization and Their Application in Animal Models of Human Diseases
Alexei A. Bogdanov,Alexei A. Bogdanov,Alexei A. Bogdanov,I. D. Solovyev,Alexander P. Savitsky +4 more
TL;DR: The ongoing development and improvement of optical signal detectors as well as the availability of biologically inert and highly specific fluorescent probes will further contribute to the introduction of fluorescence imaging into the clinic.
3
Chapter Eight - Molecular Targeting of Imaging and Drug Delivery Probes in Atherosclerosis
Cesare Casagrande,Daniela Arosio,Claudia Kusmic,Leonardo Manzoni,Luca Menichetti,Antonio L'Abbate +5 more
TL;DR: Some opportunities in Precise and selective targeting of biomolecules specifically expressed in atherosclerotic tissues can offer substantial advantages in the design of novel diagnostic tools and drug delivery systems, discriminating unstable plaques at risk of rupturing from stable ones appear to deserve further efforts of research and development.
2
References
Compensatory Enlargement of Human Atherosclerotic Coronary Arteries
Seymour Glagov,Elliot Weisenberg,Christopher K. Zarins,Regina Stankunavicius,George J. Kolettis +4 more
TL;DR: It is concluded that human coronary arteries enlarge in relation to plaque area and that functionally important lumen stenosis may be delayed until the lesion occupies 40 percent of the internal elastic lamina area.
3.8K
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
Morteza Naghavi,Peter Libby,Erling Falk,S. Ward Casscells,S. Ward Casscells,Silvio H. Litovsky,Silvio H. Litovsky,John A. Rumberger,Juan J. Badimon,Christodoulos Stefanadis,Pedro R. Moreno,Gerard Pasterkamp,Zahi A. Fayad,Peter Stone,Sergio Waxman,Paolo Raggi,Mohammad Madjid,Mohammad Madjid,Alireza Zarrabi,Alireza Zarrabi,Allen P. Burke,Chun Yuan,Peter J. Fitzgerald,David S. Siscovick,Chris L. de Korte,Masanori Aikawa,K.E. Juhani Airaksinen,Gerd Assmann,Christoph R. Becker,James H. Chesebro,Andrew Farb,Zorina S. Galis,Christopher L. Jackson,Ik-Kyung Jang,Wolfgang Koenig,Robert A. Lodder,Keith L. March,Jasenka Demirovic,Mohamad Navab,Silvia G. Priori,Mark D. Rekhter,Raymond D. Bahr,Scott M. Grundy,Roxana Mehran,Antonio Colombo,Eric Boerwinkle,Christie M. Ballantyne,William Insull,Robert S. Schwartz,Robert A. Vogel,Patrick W. Serruys,Göran K. Hansson,David P. Faxon,Sanjay Kaul,Helmut Drexler,Philip Greenland,James E. Muller,Renu Virmani,Renu Virmani,Paul M. Ridker,Douglas P. Zipes,Prediman K. Shah,James T. Willerson,James T. Willerson +63 more
TL;DR: The term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future and a quantitative method for cumulative risk assessment of vulnerable patients needs to be developed.
Shedding light onto live molecular targets
TL;DR: Optical sensing of specific molecular targets and pathways deep inside living mice has become possible as a result of a number of advances, which will provide new tools making it possible to understand more fully the functioning of protein networks, diagnose disease earlier and speed along drug discovery.
2K
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.
TL;DR: In vivo imaging showed a 12-fold increase in NIRF signal, allowing the detection of tumors with submillimeter-sized diameters, and this strategy can be used to detect such early stage tumors in vivo and to probe for specific enzyme activity.
1.7K
Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency
TL;DR: It is suggested that cathepsin K is a major protease in bone resorption, providing a possible rationale for the treatment of disorders such as osteoporosis and certain forms of arthritis.
1K